In the world of healthcare, the introduction of electronic prescribing systems has been a significant step towards modernization and efficiency. However, as we delve into the potential risks associated with these systems, a critical question arises: are we inadvertently creating new avenues for medication errors, particularly those involving 'look-alike sound-alike' (LASA) drugs?
The Human Factor in Medication Errors
One of the most fascinating aspects of this topic is the interplay between human error and technological advancement. While electronic prescribing systems were designed to reduce errors, they have introduced a new set of challenges. Take, for instance, the tragic case of Sidra Aliabase, a newborn who lost her life due to a prescribing error. This incident highlights the potential for LASA errors in electronic systems, where a simple mistake in selecting the wrong drug from a drop-down menu can have devastating consequences.
The Evolution of Prescribing Systems
The journey towards electronic prescribing began in the 1990s, with the NHS aiming for a paperless system by 2024, a target that has faced delays. Despite these challenges, the push towards electronic systems continued, with the introduction of the electronic prescribing and medicines administration (ePMA) systems. The UK government's claim that these systems can reduce medication errors by 30% is a promising statistic, but it doesn't account for the unique challenges posed by LASA errors.
Incident Data: A Complex Picture
Obtaining accurate data on LASA incidents is a challenging task. The transition from the National Reporting and Learning System (NRLS) to the Learn from Patient Safety Events (LFPSE) service created a period of potential dual reporting, making it difficult to ascertain the true scale of LASA errors. Additionally, the way these incidents are reported, often in free text, further complicates data extraction.
Replacing One Error with Another
An interesting perspective comes from Professor Bryony Dean Franklin, who suggests that LASA errors in paper-based systems may have been replaced by new errors in electronic systems. This shift in error type is an intriguing concept. Julia Scott, a pharmacist and CIO, echoes this sentiment, noting that we've potentially traded illegibility errors for drop-down menu errors. This perspective challenges the notion that electronic systems are inherently safer.
Mitigating Errors: A Multi-Pronged Approach
The fight against LASA errors requires a multifaceted strategy. One tactic is the use of 'tall-man lettering', where certain letters in drug names are capitalized to distinguish them from similar-sounding drugs. However, as Julia Scott points out, this method, while helpful, doesn't eliminate the risk entirely. She suggests changing how drugs are grouped in drop-down menus, forcing commonly confused drugs further apart to reduce the likelihood of errors.
The Promise and Perils of AI
The integration of AI into healthcare systems offers both promise and peril. On the one hand, AI-powered clinical decision support systems could help prevent LASA errors by applying logic and prompting prescribers. However, as Scott warns, the introduction of ambient voice technology (AVT) or 'AI scribes' brings a new category of sound-alike error risks. These systems, which transcribe conversations between patients and healthcare professionals, could introduce errors if they misinterpret drug names.
Other Methods to Reduce LASA Errors
Beyond AI, there are other innovative methods being explored. Touchdose, a clinical decision support system, calculates the correct dosage of a drug based on the patient's indication, reducing the likelihood of LASA errors. This system, developed by Dosium, has shown promising results in reducing prescribing errors.
Under-Reporting: A Hidden Challenge
A significant challenge in understanding the true scale of LASA errors is under-reporting. Professor Franklin notes that only a tiny fraction of prescribing and administration errors are reported, making it difficult to analyze and address these issues effectively. The reasons for under-reporting are practical, ranging from a lack of awareness to the time and energy required to report an incident.
The Role of AI in Analysis
AI has the potential to revolutionize the analysis of LASA error reporting. With its ability to process vast amounts of data, AI could help identify patterns and insights that might otherwise be missed. The hope is that the new LFPSE system, coupled with AI, will provide a more amenable environment for analysis, leading to improved patient safety.
Conclusion: A Balancing Act
The introduction of electronic prescribing systems has undoubtedly brought about many benefits, but it has also highlighted the need for continuous improvement and adaptation. As we move forward, it's crucial to strike a balance between embracing technological advancements and understanding the unique challenges they present. The fight against LASA errors is an ongoing battle, and with the potential of AI, we may eventually see a reduction in these errors. However, as Julia Scott wisely notes, with every new advancement, there will be new error mechanisms to navigate. It's a complex and ever-evolving landscape, but one that, with the right tools and mindset, we can make safer.
